Noninterventional Open-Label Trial Investigating the Efficacy and Safety of Ectoine Containing Nasal Spray in Comparison with Beclomethasone Nasal Spray in Patients with Allergic Rhinitis
Figure 1
Patient flow during the study. On day 1 (V1), patients were asked to participate in the study. 25 patients received ectoine nasal spray, and 25 patients received beclomethasone nasal spray for a treatment period of days. All 50 patients finished the study with the final study visit V2.
